Supplemental Figure 6 from Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC
crossref(2024)
摘要
Kaplan-Meier curve for (A) Overall survival (OS), (B) first-line TKI progression-free survival (PFS) and (C) PFS on first-line alectinib or brigatinib by PD-L1 high (TPS > 50%) status
更多查看译文
关键词
Survival Analysis,ALK Inhibitors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要